CollPlant Biotechnologies (CLGN) FCF Margin Growth (1y) (2019 - 2025)
CollPlant Biotechnologies (CLGN) FCF Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 769.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 19,111.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 811.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 4,109.00 |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -279,045.00 |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 13,493.00 |
| Dec 31, 2024 | -136,853.00 |
| Sep 30, 2024 | -8.27 Mn |
| Jun 30, 2024 | -146,293.00 |
| Mar 31, 2024 | -247,243.00 |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 263,855.00 |
| Jun 30, 2023 | 538,018.00 |
| Dec 31, 2022 | -2.11 Mn |
| Sep 30, 2022 | -105,853.00 |
| Jun 30, 2022 | -495,951.00 |
| Dec 31, 2021 | -25,453.00 |
| Sep 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | -68,730.00 |
| Mar 31, 2021 | -36,090.00 |
| Dec 31, 2020 | 23,112.00 |
| Sep 30, 2020 | -3.36 Mn |
| Jun 30, 2020 | 46,700.00 |